Veterinary Medicines

Rilexine 300 mg Tablets for dogs

Authorised
  • Cefalexin monohydrate
Download as PDF

Product identification

Medicine name:
Rilexine 300 mg Tablets for dogs
Active substance:
  • Cefalexin monohydrate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cefalexin monohydrate
    315.52
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • Blister packs consisting of blister aluminium - PVC/aluminium/OPA. Aluminium foil lid coated with lacquer. Cardboard Box with 2 blisters of 7 tablets.
  • Blister packs consisting of blister aluminium - PVC/aluminium/OPA. Aluminium foil lid coated with lacquer. Cardboard Box with 20 blisters of 7 tablets.
  • Blister packs consisting of blister aluminium - PVC/aluminium/OPA. Aluminium foil lid coated with lacquer.Cardboard Box with 30 blisters of 7 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent (abridged application) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10988/018/002
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 10/02/2023
Download